Herbas VPB

Print
EN | LT
LT - Kompozicijos, skirtos ilgo poveikio muskarino antagonistų ir ilgo poveikio beta 2 adrenerginio receptorius agonistų pateikimui į plaučius, ir susiję būdai ir sistemos
EN - COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING BETA-2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/12 (2006.01)
A61K 9/00 (2006.01)
A61K 9/16 (2006.01)
A61K 31/40 (2006.01)
A61K 31/167 (2006.01)
A61K 31/56 (2006.01)
A61K 31/58 (2006.01)
A61K 31/46 (2006.01)
A61K 31/137 (2006.01)
A61K 31/573 (2006.01)
A61P 11/00 (2006.01)
A61M 15/00 (2006.01)
European patent
(11) Number of the document 3106149
(13) Kind of document T
(96) European patent application number 16164845.6
Date of filing the European patent application 2010-05-28
(97) Date of publication of the European application 2016-12-21
(45) Date of publication and mention of the grant of the patent 2019-11-20
(46) Date of publication of the claims translation 2020-03-10
Priority applications
(30) Number Date Country code
182565 P 2009-05-29 US
258172 P 2009-11-04 US
309365 P 2010-03-01 US
345536 P 2010-05-17 US
Inventors
(72)
VEHRING, Reinhard, US
HARTMAN, Michael, Steven, US
SMITH, Adrian, Edward, US
JOSHI, Vidya, B, US
DWIVEDI, Sarvajna, Kumar, US
Grantee
(73) Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA 94063, US
Attorney or representative
(74) Liudmila GERASIMOVIČ, IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius, LT
Title
(54) Kompozicijos, skirtos ilgo poveikio muskarino antagonistų ir ilgo poveikio beta 2 adrenerginio receptorius agonistų pateikimui į plaučius, ir susiję būdai ir sistemos
  COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING BETA-2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS
Last renewal fee
Payment date Validity (years) Amount
2025-04-23 16 347.00 EUR
Next renewal fee
2026-05-28